VTGN 8-K 2026-07-31

Vistagen Therapeutics, Inc. (VTGN) 8-K dated 2026-07-31 — accession 0001628280-26-051251. This URL is the filing, not the VTGN hub.

Vistagen Therapeutics, Inc. (VTGN) is a biotechnology company listed on NASDAQ.

Vistagen Therapeutics, Inc. filed a 8-K on 2026-07-31. Accession 0001628280-26-051251.

Cached items: 5.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported VTGN revenue for 2026-03-31 was $1.3M. Net income was -$69.7M. Revenue was up 161.1% from 2025-03-31 to 2026-03-31. VTGN currently screens at market cap $28.1M.

Not investment advice. The VTGN SEC hub lists recent forms. The stock page is the research view.